Point-of-care CAR-T cell manufacturing as a path to equity in cancer immunotherapy in a middle-income country

Cao HM, Aigner M (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Molecular Therapy Oncology Cell Press

Book Volume: 34

Article Number: 201290

Journal Issue: 3

DOI: 10.1016/j.omton.2026.201290

Involved external institutions

Hanoi Medical University (HMU) / Trường Đại học Y Hà Nội (HMU) VN Viet Nam (VN)

How to cite

APA:

Cao, H.M., & Aigner, M. (2026). Point-of-care CAR-T cell manufacturing as a path to equity in cancer immunotherapy in a middle-income country. Molecular Therapy Oncology, 34(3). https://doi.org/10.1016/j.omton.2026.201290

MLA:

Cao, Ha My, and Michael Aigner. "Point-of-care CAR-T cell manufacturing as a path to equity in cancer immunotherapy in a middle-income country." Molecular Therapy Oncology 34.3 (2026).

BibTeX: Download